CHLOROPROCAINE HYDROCHLORIDE
| Brand name | CLOROTEKAL |
|---|---|
| Active ingredient | CHLOROPROCAINE HYDROCHLORIDE |
| Strength | 50MG/5ML (10MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRATHECAL |
| Modality | Small molecule |
| FDA approval | September 2017 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 9504666 | December 2033 | product |
| 8969412 | September 2026 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.